Francine Behar-Cohen discusses the treatment needs in CNV including effective anti-angiogenic drugs to inhibit the growth and survival of the neovessels and effective control of the scarring process. The introduction of OCT-A has proven useful in the identification of CNV but the real challenge is understanding when and when not to treat CNV, and which treatment approach to use. Looking to the future, whilst combination treatment of anti-VEGF therapies with corticosteroids steroids has not shown to effective through clinical trial but other drug combinations should be explored.
Keywords: CNV, anti-VEGF, anti-angiogenic, scarring, diagnosis, OCT-A, optical coherence tomography angiography, inflammation, AMD, corticosteroids, efficacy, future research.
Filmed by Touch Medical Media. No external funding was involved in the production of this video.